Office of Health Economics, London, UK.
University of Nottingham, Nottingham, UK.
J Med Econ. 2024 Jan-Dec;27(1):1119-1123. doi: 10.1080/13696998.2024.2395741. Epub 2024 Aug 29.
The Vaccines Task Force was established by the UK government in March 2020, with the objective of securing early access to effective COVID-19 vaccines for the UK population and internationally. The VTF was successful in securing the earliest access to the Oxford/Astra Zeneca and Pfizer/BioNTech vaccines, allowing the UK to be the first country in the world to deploy an approved COVID-19 vaccine. The VTF also played a critical role in supporting efforts to distribute vaccines globally, as one of COVAX's earliest and largest donors. This article presents the perspectives of senior members of the VTF on the features of the task force model which enabled this success, and considers lessons for when and how a similar approach should be applied to other public health and public policy challenges. We seek to identify principles for mission led government, and implications for how the structure and apparatus of governance can be organised to support this, including the application of the Task Force model where appropriate.
疫苗专责小组是由英国政府于 2020 年 3 月成立的，旨在为英国和国际社会争取尽早获得有效的 COVID-19 疫苗。该专责小组成功争取到最早获得牛津/阿斯利康和辉瑞/生物新技术疫苗的机会，使英国成为全球首个部署获批准 COVID-19 疫苗的国家。专责小组亦在支持全球分发疫苗方面发挥了关键作用，是 COVAX 的最早和最大捐助者之一。本文介绍了专责小组成员对促成这一成功的专责小组模式特点的看法，并探讨了在何时以及如何将类似方法应用于其他公共卫生和公共政策挑战的经验教训。我们旨在确定以任务为导向的政府的原则，并探讨治理结构和机制如何组织以支持这一点，包括在适当情况下应用专责小组模式。
